Biomedical research proteomics

Figure 15.2). The combination of proteomics and genomics will play a major role in biomedical research and will have a significant impact on the development of the diagnostic and therapeutic products of the future. 

Novartis Institutes for BioMedical Research, Genome and Proteome Sciences/ Systems Biology, Basel, Switzerland. 

MS is the most common label-free technique widely used in proteomics, with many different applications in very different areas from environmental to biomedical research MS especially has become one of the leading methodologies in the field of biomarker discovery. Before MS was applied to protein... 

In addition to commercially production, a great deal of research and development work on biochips has been going on both in industry and in academia. Genomic analysis of DNA and RNA continues to be the focus of interest, but more and more effort is being spent on proteomic analysis of proteins and peptides. Several enzyme assays and immunoassays designed based on microarray-based systems with simple microfluidic control are close to commercialization. They can be a vital tool in clinic diagnostics, drug discovery, and biomedical research. 

In recent years, interest in proteins has surged. This resui ence lias been driven by the expansion of the post-genomic era when structural genomics and proteomics require new techniques in protein chemistry and new applications of older techniques. Protein chemistry methods are used by nearly every discipline of biomedical research. Many techniques have been used in loss traditional ways with exciting results. Modern Protein Chemtsiry Practical Aspects descril>es tlie practical side of advanced techniques in protein chemistry. The book gives researcliers an excellent "cost-benefit" analysis of these techniques. 

Catherine C. Fenselau is a professor of chemistry and biochemistry at the University of Maryland, College Park. She has been a pioneer in the application of mass spectrometry in biomedical research. Her current interests include the use of proteomic strategies to investigate cellular mechanisms of acquired drug resistance and as the basis for detection and analysis of... 

Why is it important to accept this challenge A current and near future priority of biomedical research is to understand and treat complex diseases like diabetes, heart disease, and cancer that have only recently become prevalent sources of morbidity and mortality in human populations. A major goal of systems biology and proteomics is to identify and quantify specific proteins for use as predictive diagnostic and/or prognostic biomarkers of disease [32]. Biomarker discovery is... 

In quantitative proteomics studies, the most frequently employed method is enzyme-linked immunosorbent assay (ELISA) [88]. This sensitive and reliable, competition-based color reaction approach is widely used both in biomedical research and clinical diagnostics [89-91]. 

Rodriguez-Suarez, E and Whetton, A. D. 2013. The application of quantification techniques in proteomics for biomedical research. Mass Spectrom. Rev. 32 1-26. 

MARTIJN W.H. Pinkse Kluyver Laboratory, Department of Biotechnolopiy, Netherlands Proteomics Center, Delft University ofTechnolopfy, Delft, The Netherlands Brendan Prideaux Analytical Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland... 

---